FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells

Published:2023-12-21 Issue:2 Volume:64 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Naeem Abdulghani¹,Abdulsamad Saud¹,Zeng Hao¹,He Gang²,Jin Xi¹,Zhang Jiacheng²,Alenezi Bandar²,Ma Hongwen¹,Rudland Philip³,Ke Youqiang¹

Affiliation:

1. Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

2. Department of Molecular and Clinical Cancer Medicine, Liverpool University, Liverpool L69 3PX, UK

3. Department of Biochemistry and Systems Biology, Liverpool University, Liverpool L69 3PX, UK

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference53 articles.

1. Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5-a population-based study;De Angelis;Lancet Oncol,2014

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. Studies on prostatic cancer: II. the effects of castration on advanced carcinoma of the prostate gland;Huggins;Arch Surg,1941

4. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

5. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941;Huggins;J Urol,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment;Heliyon;2024-05

2. Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use;American Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3